Published medical evidence has shown that compounds from medicinal fungi significantly stimulate the immune system. Research ongoing worldwide regarding, for example, β-glucan’s efficacy in cancer therapy and combating infectious diseases.
GlycaNova has presently one clinical and two preclinical pharmaceutical products.
GlycaNova has an additional pipeline of products, in which immune stimulating properties have been demonstrated. The production processes for all these products have been developed.
All GlycaNova products are taken orally.